1. Scrip
  2. >>Focus On Asia

Merck KGaA Seeks Production Plants In ASEAN

Thailand and other member countries of the ASEAN economic community are being inspected by Merck KGaA as possible locations for production plants that it plans to build to take advantage of cheaper labor costs.

Thailand and other member countries of the ASEAN (Association of South East Asian Nations) economic community are being inspected by Merck KGAA as possible locations for production plants that it plans to build to take advantage of cheaper labor costs. The Germany-based drug maker seeks to have final plant sites selected by the end of 2015. In Thailand, Merck now relies on a local factory to produce one of its vitamins, and the head of Merck Thailand said the unit expects to grow by up to 5% this year. (Click here for more

)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Focus On Asia

Is Zydus’s Agenus Deal Opportunistic Or Strategic?

 
• By Vibha Ravi

Will Zydus’s acquisition and licensing deal with Agenus turn out to be a strategic move towards building an oncology portfolio or an opportunistic one driven by a venture capital mindset?

Citeline Japan Awards 2025 - Enter Now!

 
• By Ian Haydock and Lisa Takagi

The 14 July deadline for the Citeline Japan Awards 2025 in Tokyo is approaching fast, so here's a reminder to take a look at the categories and criteria and be sure to get those submissions in by this date. Sponsorship opportunities and tables for the event are also available.

Crisis Or Opportunity? US MFN Policy Could Test Japan’s Appetite For Reforms

 
• By Lisa Takagi

While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.

Pharma’s Space Trails Entering Transformative Era - Keytruda’s Been There

 
• By Anju Ghangurde

Merck and Lilly are among the leading pharma players using space-based research to power drug development. From reusable satellites to process drugs in low earth orbit to biomanufacturing labs experts discuss R&D opportunities in the starry canvas above.

More from Scrip